Loading...
Docoh

Cerus (CERS)

Cerus Corporation is dedicated solely to safeguarding the world's blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. The INTERCEPT red blood cell system is under regulatory review in Europe, and in late-stage clinical development in the US. Also in the US, the INTERCEPT Blood System for Cryoprecipitation is approved for production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex, a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency.

Company profile

CERS stock data

Calendar

4 May 22
26 Jun 22
31 Dec 22
Quarter (USD) Mar 22 Dec 21 Sep 21 Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 40.38M 40.38M 40.38M 40.38M 40.38M 40.38M
Cash burn (monthly) 3.56M 1.62M 4.07M 4.08M 7.15M 3.16M
Cash used (since last report) 10.22M 4.65M 11.7M 11.71M 20.56M 9.08M
Cash remaining 30.15M 35.72M 28.68M 28.66M 19.82M 31.29M
Runway (months of cash) 8.5 22.1 7.0 7.0 2.8 9.9

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
1 Jun 22 Eric Bjerkholt Common Stock Grant Acquire A No No 0 20,454 0 77,133
1 Jun 22 Eric Bjerkholt Option Common Stock Grant Acquire A No No 4.84 39,866 192.95K 39,866
1 Jun 22 Moore Timothy L. Common Stock Grant Acquire A No No 0 20,454 0 65,073
1 Jun 22 Moore Timothy L. Option Common Stock Grant Acquire A No No 4.84 39,866 192.95K 39,866
1 Jun 22 Jami K Nachtsheim Common Stock Grant Acquire A No No 0 20,454 0 66,362
1 Jun 22 Jami K Nachtsheim Option Common Stock Grant Acquire A No No 4.84 39,866 192.95K 39,866
1 Jun 22 Schulze Gail Common Stock Grant Acquire A No No 0 20,454 0 48,570
1 Jun 22 Schulze Gail Option Common Stock Grant Acquire A No No 4.84 39,866 192.95K 39,866
1 Jun 22 Daniel N Swisher JR Common Stock Grant Acquire A No No 0 20,454 0 113,808
1 Jun 22 Daniel N Swisher JR Option Common Stock Grant Acquire A No No 4.84 39,866 192.95K 39,866
84.2% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 183 184 -0.5%
Opened positions 25 28 -10.7%
Closed positions 26 16 +62.5%
Increased positions 68 52 +30.8%
Reduced positions 49 66 -25.8%
13F shares Current Prev Q Change
Total value 806.61M 1.01B -20.2%
Total shares 148.92M 148.64M +0.2%
Total puts 219.4K 324.2K -32.3%
Total calls 392.8K 306.1K +28.3%
Total put/call ratio 0.6 1.1 -47.3%
Largest owners Shares Value Change
ARK Investment Management 16.21M $89.01M +2.9%
Baker Bros. Advisors 13.71M $75.29M 0.0%
BLK Blackrock 12.16M $66.78M -0.4%
CMTDF Sumitomo Mitsui Trust 10.64M $58.4M -7.7%
Nikko Asset Management Americas 10.64M $48.93M -7.7%
Primecap Management 9.53M $52.33M -2.0%
Vanguard 9.04M $49.64M +2.5%
Wasatch Advisors 8.43M $46.26M +2.9%
STT State Street 4.63M $25.45M +4.3%
Senvest Management 4.19M $22.99M +14.8%
Largest transactions Shares Bought/sold Change
CMTDF Sumitomo Mitsui Trust 10.64M -892.41K -7.7%
Nikko Asset Management Americas 10.64M -892.41K -7.7%
Natixis 745.4K +745.4K NEW
Tamarack Advisers 1.65M +650K +65.0%
Granahan Investment Management 0 -645.57K EXIT
Kennedy Capital Management 1.41M -637.92K -31.2%
Senvest Management 4.19M +539.6K +14.8%
Altium Capital Management 0 -465K EXIT
ARK Investment Management 16.21M +455.8K +2.9%
Hood River Capital Management 1.7M -433.71K -20.3%

Financial report summary

?

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. senior Avg
New words: absent, affiliate, affix, affixing, bacterium, broaden, Chinese, chose, Colorado, comparison, conferencing, correspondingly, cultural, Delta, endpoint, exfiltrated, foreseeable, guided, III, inflation, inflationary, Noncontrolling, objectionable, Omicron, pendency, post, proportion, remote, resolution, reticence, secret, shortfall, situation, strained, theft, timeframe, unfamiliar, variation, vendor, video, vigilance, Virginia, war
Removed: absence, absenteeism, abundance, acid, acting, Affordable, Aid, amotosalen, anesthesiologist, announcement, Ash, batch, BCT, begun, Biopharma, Bipartisan, breadth, brokerage, Brotech, Canadian, cap, caution, certified, characterized, choice, collecting, compensate, consequential, continual, convince, cooperation, covenant, declared, decree, dedicated, delivered, derivative, detrimental, devalue, diagnostic, diminished, directed, disagree, discontinued, discrepant, distancing, distrust, domiciled, DSMB, dynamic, emerge, Emergency, encouraged, ensuing, entry, epidemic, escalating, ethical, Eurozone, expensed, Favored, finalize, finalized, fine, footprint, formality, Framework, French, front, frozen, globe, guilty, handle, harbor, HHS, horizon, hurricane, ill, importation, improved, inactivating, incidental, infiltrated, influx, inherently, injunction, insolvent, intention, interested, invoicing, jurisdiction, Justice, Kedrion, lawfully, levied, lifting, locally, Louisiana, lowest, mammalian, mature, metric, MINE, minimize, misleading, misstatement, multinational, mutually, Nova, nucleic, occurring, Octapharma, optimized, outbreak, outcome, permitted, pharmacy, Porex, pose, predictive, prepaid, prescribe, prescription, Presently, problem, Producer, Purolite, rapid, reached, reagent, recapture, reconciliation, reconfigured, recordkeeping, refile, reflected, reliable, removal, removing, renew, repeat, responded, resumed, resumption, resurgence, retaliatory, retroactive, reveal, risky, SA, saleable, scheduled, SENIOR, serve, setting, Shield, significance, skill, slowly, social, spike, stage, standardized, stimulate, suitability, suitable, surveillance, Swissmedic, symbol, synthetic, thawing, threaten, threatened, threshold, tie, traceability, Trump, truthful, Turkey, typical, unacceptable, uneven, unprecedented, UNREGISTERED, usability, vaccine, vested, viewed, violate, violating, vote, waived, weaken, Wisconsin, withdrawn, writing